相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overexpressed P75CUX1 promotes EMT in glioma infiltration by activating β-catenin
Anqi Xu et al.
CELL DEATH & DISEASE (2021)
Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia
Emmanuelle Supper et al.
NATURE COMMUNICATIONS (2021)
Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms
Molly K. Imgruet et al.
BLOOD (2021)
Splicing Kinetics and Coordination Revealed by Direct Nascent RNA Sequencing through Nanopores
Heather L. Drexler et al.
MOLECULAR CELL (2020)
The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer
Emma R. Dorris et al.
Oncotarget (2020)
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications
Sebastia Franch-Exposito et al.
ELIFE (2020)
The Physiological Functions of the Golgin Vesicle Tethering Proteins
Martin Lowe
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Ann Lin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Distinct clinical and biological implications of CUX1 in myeloid neoplasms
Mai Aly et al.
BLOOD ADVANCES (2019)
Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS
Ningfei An et al.
BLOOD (2018)
Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus
Jia Chen et al.
NATURE MICROBIOLOGY (2018)
CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials
Ann Lin et al.
ELIFE (2017)
Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma
Melissa A. Wilson et al.
CLINICAL CANCER RESEARCH (2016)
A method for whole protein isolation from human cranial bone
Sarah M. Lyon et al.
ANALYTICAL BIOCHEMISTRY (2016)
Recursive splicing in long vertebrate genes
Christopher R. Sibley et al.
NATURE (2015)
The dynamic interactome of human Ahal upon Y223 phosphorylation
Donald Wolfgeher et al.
DATA IN BRIEF (2015)
The quantitative changes in the yeast Hsp70 and Hsp90 interactomes upon DNA damage
Andrew W. Truman et al.
DATA IN BRIEF (2015)
A promoter-level mammalian expression atlas
Alistair R. R. Forrest et al.
NATURE (2014)
Inactivating CUX1 mutations promote tumorigenesis
Chi C. Wong et al.
NATURE GENETICS (2014)
Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers
Charles Vadnais et al.
BIOLOGY OPEN (2014)
CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers
Zubaidah M. Ramdzan et al.
NATURE REVIEWS CANCER (2014)
CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia
Megan E. McNerney et al.
BLOOD (2013)
Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome
Teresa Davoli et al.
CELL (2013)
EPD and EPDnew, high-quality promoter resources in the next-generation sequencing era
Rene Dreos et al.
NUCLEIC ACIDS RESEARCH (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
GENCODE: The reference human genome annotation for The ENCODE Project
Jennifer Harrow et al.
GENOME RESEARCH (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
ChromHMM: automating chromatin-state discovery and characterization
Jason Ernst et al.
NATURE METHODS (2012)
Analysis of protein isoforms: Can we do it better?
Miroslava Stastna et al.
PROTEOMICS (2012)
Mapping and analysis of chromatin state dynamics in nine human cell types
Jason Ernst et al.
NATURE (2011)
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer
S. Ripka et al.
GUT (2010)
Mouse Mammary Tumor Virus p75 and p110 CUX1 Transgenic Mice Develop Mammary Tumors of Various Histologic Types
Chantal Cadieux et al.
CANCER RESEARCH (2009)
p110 CUX1 Homeodomain Protein Stimulates Cell Migration and Invasion in Part through a Regulatory Cascade Culminating in the Repression of E-cadherin and Occludin
Valerie Kedinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice
Rania Siam et al.
MOLECULAR CANCER (2009)
Using native and syntenically mapped cDNA alignments to improve de novo gene finding
Mario Stanke et al.
BIOINFORMATICS (2008)
The multiple roles of CUX1: Insights from mouse models and cell-based assays
Laurent Sansregret et al.
GENE (2008)
Polycystic kidneys caused by sustained expression of Cux1 isoform p75
Chantal Cadieux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
BAC TransgeneOmics:: a high-throughput method for exploration of protein function in mammals
Ina Poser et al.
NATURE METHODS (2008)
Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes
Ryoko Harada et al.
NUCLEIC ACIDS RESEARCH (2008)
Carboxyl-terminal proteolytic processing of CUX1 by a caspase enables transcriptional activation in proliferating cells
Mary Truscott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation
Brigitte Goulet et al.
MOLECULAR CANCER RESEARCH (2007)
Differentiation-induced cleavage of Cutl1/CDP generates a novel dominant-negative isoform that regulates mammary gene expression
Urmila Maitra et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Transgenic mice expressing the p75 CCAAT-displacement protein/cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia
Chantal Cadieux et al.
CANCER RESEARCH (2006)
A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L
Brigitte Goulet et al.
BIOLOGICAL CHEMISTRY (2006)
The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase
L Sansregret et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness
P Michl et al.
CANCER CELL (2005)
Goigin tethers define subpopulations of COPI vesicles
J Malsam et al.
SCIENCE (2005)
NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins
KD Pruitt et al.
NUCLEIC ACIDS RESEARCH (2005)
Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage
T Shiraki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
CASP, the alternatively spliced product of the gene encoding the CCAAT-displacement protein transcription factor, is a Golgi membrane protein related to giantin
AK Gillingham et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27kip1 expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasia
AW Ledford et al.
DEVELOPMENTAL BIOLOGY (2002)
The Ensembl genome database project
T Hubbard et al.
NUCLEIC ACIDS RESEARCH (2002)
Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice
AM Sinclair et al.
BLOOD (2001)
S phase-specific proteolytic cleavage is required to activate stable DNA binding by the CDP/Cut homeodomain protein
NS Moon et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
CCAAT displacement activity involves CUT repeats 1 and 2, not the CUT homeodomain
NS Moon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Large-scale human promoter mapping using CpG islands
IP Ioshikhes et al.
NATURE GENETICS (2000)
分享论文
